June 15-16, 2026 Paris, France
"One World, One Mission: Tackling Obesity, Diabetes & Metabolic Disease"
Elevate Your Career — Attend the Conference to Secure Your CPD Credits
The Global Congress on Obesity, Diabetes and Metabolic Health(ODMH Con 2026) is a premier international event scheduled to be held on June 15-16, 2026 at Paris, France dedicated to advancing research, treatment, and prevention strategies for some of today’s most widespread chronic conditions. Over two days, experts from around the world will gather to share groundbreaking discoveries, innovative therapies, and evidence-based best practices. The conference provides a dynamic platform for multidisciplinary collaboration, bridging the gap between laboratory science, clinical care, and public health initiatives. Participants will engage in keynote presentations, panel discussions, and interactive workshops designed to foster knowledge exchange and inspire new approaches to tackling metabolic health challenges.
Hosted in the vibrant city of Paris, this congress offers a unique blend of scientific excellence and cultural richness. Attendees will benefit from networking opportunities with leading clinicians, researchers, policymakers, and industry innovators. The event emphasizes translating scientific insights into practical solutions that can improve patient outcomes and inform health policies globally. By fostering a holistic understanding of obesity, diabetes, and metabolic health, the congress aims to empower healthcare professionals and stakeholders to drive meaningful change and enhance the quality of life for affected populations worldwide.
This congress seeks to accelerate the understanding, prevention, and management of obesity, diabetes, and metabolic health disorders by fostering collaboration across disciplines and borders. The purpose is to bridge research and clinical practice, promote innovative therapies, and highlight public health initiatives to combat these global health challenges.
Why It Matters
Obesity, diabetes, and metabolic disorders are among the most pressing global health challenges today, affecting hundreds of millions of people and placing immense strain on healthcare systems worldwide. These conditions not only increase the risk of severe complications such as cardiovascular disease, kidney failure, and stroke but also significantly reduce quality of life and life expectancy. Addressing them requires urgent, coordinated action that integrates the latest scientific discoveries with practical clinical approaches and public health strategies. This congress matters because it fosters collaboration, innovation, and knowledge-sharing essential to reversing the rising tide of metabolic diseases and improving health outcomes for populations across the globe.
Attendees will gain:
CRISPR-Edited Islet Cells for Type 1 Diabetes
Oral GLP-1 Receptor Agonists
Dual Incretin Agonists (GLP-1 + GIP)
Once-Weekly Insulin Therapies
GLP-1 Receptor Agonists for Cardiovascular & Renal Protection
Implantable Continuous Glucose Monitors (CGMs)
Automated Insulin Delivery Systems / Closed-Loop Pumps
Digital Twin Models for Personalized Diabetes Care
Continuous Ketone Monitoring for High-Risk Patients
AI & Machine Learning for Glucose Prediction and Diabetes Management
2025 ADA Standards of Care in Diabetes
Personalized Pharmacological Strategies
Evidence-Based Dietary Interventions
Real-World Evidence & Outcomes in Diabetes Treatment
Management of Comorbidities in Diabetes (Obesity, Hypertension, Dyslipidemia)
Global Targets & Strategies to Halt Diabetes Rise
Access to Affordable Insulin Worldwide
Diabetes Education & Awareness Programs
Innovations in Diabetes Care in Low-Resource Settings
Collaborative International Research in Diabetes
May 15, 2026
June 15, 2026
May 15, 2026
I’m really looking forward to this year’s conference on obesity, diabetes, and metabolic health! The focus on new therapeutic strategies for Type 2 diabetes and obesity management is exactly what I need to push my research forward. I’m excited to learn from the top minds in the field.
Diabetes Research Institute, United States, United States
This conference is a must-attend for anyone working in metabolic health. The discussions on the latest treatments for insulin resistance and the role of diet in obesity management have been incredibly insightful. I’ve already gained valuable ideas that I can apply to my clinical practice.
Deaprtment of Endocrinology, Italy , Italy
Attending this conference has been an outstanding experience. The workshops on personalized nutrition for diabetes management and the deep dives into obesity-related comorbidities were particularly useful. It’s refreshing to see such practical and evidence-based approaches being discussed.
Endocrinologist, United Kingdom, United Kingdom
I’m eagerly awaiting this conference. The chance to explore the latest developments in metabolic syndrome and obesity interventions is something I’ve been looking forward to. I’m particularly excited about the discussions on the role of genetics in obesity and diabetes.
Consultant in Metabolic Diseases, Switzerland, Switzerland
I can’t wait for the conference to start! As a resident, I’m thrilled about the opportunity to learn more about the intersection of metabolic diseases and cardiovascular health. The chance to network with leading experts in the field is invaluable for my growth as a clinician.
Department of Endocrinology, Denmark, Denmark
